Martingale Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $619K | Sell |
4,505
-631
| -12% | -$86.7K | 0.02% | 581 |
|
|
2025
Q1 | $926K | Hold |
5,136
| – | – | 0.02% | 483 |
|
|
2024
Q4 | $805K | Buy |
5,136
+1
| +0% | +$157 | 0.02% | 522 |
|
|
2024
Q3 | $935K | Hold |
5,135
| – | – | 0.02% | 470 |
|
|
2024
Q2 | $943K | Sell |
5,135
-699
| -12% | -$128K | 0.02% | 456 |
|
|
2024
Q1 | $1.04M | Sell |
5,834
-5,853
| -50% | -$1.04M | 0.02% | 460 |
|
|
2023
Q4 | $1.45M | Sell |
11,687
-80
| -0.7% | -$9.93K | 0.03% | 364 |
|
|
2023
Q3 | $1.36M | Sell |
11,767
-301
| -2% | -$34.9K | 0.03% | 350 |
|
|
2023
Q2 | $1.42M | Sell |
12,068
-1,540
| -11% | -$181K | 0.03% | 351 |
|
|
2023
Q1 | $1.09M | Hold |
13,608
| – | – | 0.02% | 422 |
|
|
2022
Q4 | $1.08M | Buy |
13,608
+9,005
| +196% | +$713K | 0.02% | 431 |
|
|
2022
Q3 | $321K | Buy |
+4,603
| New | +$321K | 0.01% | 705 |
|
|
2021
Q4 | – | Sell |
-13,406
| Closed | -$700K | – | 857 |
|
|
2021
Q3 | $700K | Buy |
13,406
+6,900
| +106% | +$360K | 0.01% | 589 |
|
|
2021
Q2 | $443K | Sell |
6,506
-100
| -2% | -$6.81K | 0.01% | 619 |
|
|
2021
Q1 | $510K | Sell |
6,606
-100
| -1% | -$7.72K | 0.01% | 601 |
|
|
2020
Q4 | $403K | Sell |
6,706
-27,700
| -81% | -$1.66M | ﹤0.01% | 668 |
|
|
2020
Q3 | $1.48M | Sell |
34,406
-22,999
| -40% | -$991K | 0.02% | 508 |
|
|
2020
Q2 | $2.38M | Buy |
57,405
+32,605
| +131% | +$1.35M | 0.03% | 471 |
|
|
2020
Q1 | $1.07M | Buy |
+24,800
| New | +$1.07M | 0.01% | 658 |
|